Abbott has introduced its Ultreon 1.0 Software in India, a vascular imaging platform that integrates optical coherence tomography (OCT) with artificial intelligence (AI).

The software provides a comprehensive view of blood flow patterns and obstructions in coronary arteries, distinguishing between calcified and non-calcified blockages, gauging calcium-based obstruction severity, and accurately measuring vessel diameters.

It also aids physicians in precise stent placement, optimal expansion, and alignment, and provides real-time results for coronary stenting procedures.

Abbott's OCT technology uses near-infrared light to provide detailed, precise imaging of blood vessels, enabling physicians to gather vital information from intricate anatomies. The software streamlines workflow, promoting swift decision-making and allowing healthcare providers to prioritize patient care and enhance their overall well-being, eliminating uncertainties.

Through the introduction of Ultreon 1.0 Software, Abbott continues to harness the capabilities of OCT technology to support healthcare professionals in making more informed treatment choices for their patients.

Tushar Sharma, General Manager for Abbott’s vascular business in India and South Asia said, “Increased adoption of OCT imaging, when combined with advanced technology like AI, allows cardiologists to have a more precise and measurable way of supporting patients undergoing coronary stent procedures. Ultreon 1.0 Software can potentially improve physician and patient experience by increasing accuracy of diagnosis and application of therapies. It takes the guesswork out of stent placement.”